Rafael Blesa
Hospital de la Sta Creu i Sant Pau
Barcelona
Spain
Name/email consistency: high
- Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Blesa, R., Ballard, C., Orgogozo, J.M., Lane, R., Thomas, S.K. Neurology (2007)
- Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Blesa, R., Bullock, R., He, Y., Bergman, H., Gambina, G., Meyer, J., Rapatz, G., Nagel, J., Lane, R. Pharmacogenet. Genomics (2006)
- Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease. Blesa, R., Aguilar, M., Casanova, J.P., Boada, M., Martínez, S., Alom, J., de la Hoz, C.H., Sancho, J., Fernández, O., Gil-Neciga, E., Massó, J.F. Alzheimer. Dis. Assoc. Disord (2006)
- Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. Blesa, R. Alzheimer. Dis. Assoc. Disord (2004)